About
Genetix Biotherapeutics develops one-time administered gene therapies that treat the underlying causes of rare genetic diseases such as sickle cell disease, β-thalassemia, and cerebral adrenoleukodystrophy.
Explore Genetix Biotherapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.